Related Experiment Video
Updated: Jun 23, 2026
07:25
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
[Chronic hepatitis B: current therapy].
1Hépatogastroentérologie, Hôpital de Bicêtre, 78, rue du Général Leclerc, 94270 Kremlin-Bicetre. catherine.buffet@bct.ap-hop-paris.fr
Bulletin De L'Academie Nationale De Medecine
|May 19, 2009
Summary
Chronic hepatitis B (HBV) infection persists due to viral DNA, necessitating long-term treatment. Current therapies suppress HBV DNA, slowing disease and preventing cancer, but do not offer a complete cure.
Area of Science:
- Hepatology and Virology
- Infectious Diseases
- Pharmacology
Background:
- Hepatitis B virus (HBV) infection is challenging to eradicate due to persistent covalently closed circular DNA (cccDNA) in hepatocytes.
- While a complete cure for chronic HBV is rare, effective suppression of HBV DNA can mitigate liver disease progression and reduce hepatocellular carcinoma risk.
Purpose of the Study:
- To review current treatment strategies for chronic hepatitis B.
- To discuss the efficacy, limitations, and adverse effects of available therapies, including pegylated interferon and oral nucleoside/nucleotide analogs.
Main Methods:
- Review of existing literature on chronic hepatitis B treatments.
- Analysis of therapeutic options: pegylated interferon and oral nucleoside/nucleotide analogs (lamivudine, adefovir, entecavir, tenofovir).
Main Results:
- Pegylated interferon offers a defined treatment duration but has limited efficacy (30-40%) and poor tolerability.
- Oral nucleoside/nucleotide analogs have minor adverse effects but can lead to viral resurgence upon discontinuation, suggesting indefinite treatment.
- Viral resistance to nucleoside/nucleotide analogs is a concern, though potent viral suppression can minimize this risk.
Conclusions:
- Current chronic hepatitis B treatments focus on viral suppression rather than eradication.
- Therapeutic decisions involve balancing efficacy, tolerability, and the risk of viral resurgence or resistance.
- Long-term management strategies are crucial for controlling HBV infection and its complications.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
01:24Chronic Pancreatitis I: Introduction
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...